Direct isolation of donor-derived CMV-specific T-cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic HSCT

被引:0
|
作者
Lowdell, M. W. [1 ]
Thomson, K. [1 ]
Armoogum, J. [1 ]
Pang, K. [1 ]
Samuel, E. [1 ]
Desborough, M. [1 ]
Mackinnon, S. [1 ]
机构
[1] Royal Free & UCL Med Sch, London, England
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S54 / S54
页数:1
相关论文
共 50 条
  • [21] Efficient induction and isolation of CMV-specific CD8+ T cells from CMV seronegative donors for the treatment of CMV reactivation in CMV seropositive patients transplanted with a CMV seronegative donor
    Jedema, Inge
    De Meent, Marian Van
    Van der Heiden, Pim L. J.
    Marijt, Erik W. A.
    Meij, Pauline
    Willemze, Roel
    Falkenburg, J. H. Frederik
    BLOOD, 2007, 110 (11) : 319A - 319A
  • [22] Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients
    Zhou, Wendi
    Longmate, Jeff
    Lacey, Simon F.
    Palmer, Joycelynne M.
    Gallez-Hawkins, Ghislaine
    Thao, Lia
    Spielberger, Ricardo
    Nakamura, Ryotaro
    Forman, Stephen J.
    Zaia, John A.
    Diamond, Don J.
    BLOOD, 2009, 113 (25) : 6465 - 6476
  • [23] Comparison of Transplant Donor and Third-Party Donor Derived CMV-Specific T Cells for CMV Infection after Allogenic Stem Cell Transplantation
    Pei, Xuying
    Liu, Xuefei
    Zhao, Xiang-Yu
    Chang, Yingjun
    Lv, Meng
    Mo, Xiaodong
    Sun, Yuqian
    Xu, Lanping
    Wang, Yu
    Zhang, Xiaohui
    Huang, Xiaojun
    BLOOD, 2021, 138
  • [24] Effective recovery of functional CD4+ CMV-specific helper T-cells in the presence of CMV-specific CD8+ T-cells is pivotal for prevention of recurrent CMV-reactivation following allogeneic stem cell transplantation (SCT).
    Cornelissen, JJ
    Brooimans, R
    Niesters, HAG
    Southwick, PC
    Sullivan, LA
    van Doornum, G
    Lowenberg, B
    Gratama, JW
    BLOOD, 2003, 102 (11) : 41A - 41A
  • [25] Recovery of CMV-Specific T Cells Following Alternative Donor Allogeneic Transplant with Post-Transplant Cyclophosphamide
    Saad, Ayman
    Langford, Samantha B.
    Mineishi, Shin
    Lamb, Lawrence S., Jr.
    BLOOD, 2015, 126 (23)
  • [26] CMV-specific T-Cells for Treatment of CMV Infection after Hematopoietic Stem Cell Transplantation in a Pediatric Case: First Application in Turkey
    Celilova, Sevil
    Toret, Ersin
    Adakli, Basak Aksoy
    Ovali, Ercument
    Bozkurt, Ceyhun
    TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (01) : 65 - 67
  • [27] Isolation of cytomegalovirus (CMV) specific T-cells from sersopositve donors: A possible tool for CMV-prophylaxis.
    Borchers, S
    Topp, M
    Ganser, A
    Einsele, H
    Weissinger, EM
    Hertenstein, B
    BLOOD, 2005, 106 (11) : 850A - 850A
  • [28] Adoptive T Cell Therapy of Human CMV Infection in Immunocompromised Hosts: In Vitro Generation of CMV-Specific T Cells from Naive Precursors
    Schmucker, Sonja
    Assenmacher, Mario
    Schmitz, Jurgen
    Richter, Anne
    BLOOD, 2008, 112 (11) : 83 - 83
  • [29] CMV-specific T cells restricted by donor, host and shared HLA molecules reconstitute with different kinetics and differentially impact the incidence of CMV reactivations after allogeneic-HSCT
    Tassi, Elena
    Noviello, Maddalena
    De Simone, Pantaleo
    Serio, Francesca
    Lupo-Stanghellini, Maria Teresa
    Oliveira, Giacomo
    Racca, Sara
    Dvir, Roee
    Lazzari, Lorenzo
    Clerici, Daniela
    Giglio, Fabio
    Lorentino, Francesca
    Corti, Consuelo
    Bernardi, Massimo
    Brix, Liselotte
    Ciceri, Fabio
    Peccatori, Jacopo
    Greco, Raffaella
    Bonini, Chiara
    BONE MARROW TRANSPLANTATION, 2019, 54 : 115 - 116
  • [30] Adoptive transfer of CMV-specific T-cells selected for IFN-gamma secretion by magnetic labeling: A closer look on the selected cells
    Borchers, S.
    Heuer, M.
    Hertenstein, B.
    Alves, J.
    Ganser, A.
    Weissinger, E. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 458 - 458